Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report.
about
Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review.Phosphoinositide 3-kinase: a new kid on the block in vascular anomalies.Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group.Neurocutaneous Syndromes and Brain Tumors.Key considerations in the treatment of von Hippel-Lindau disease.Von Hippel-Lindau disease: a single gene, several hereditary tumors.
P2860
Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 February 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pazopanib therapy for cerebell ...... l-Lindau disease: case report.
@en
Pazopanib therapy for cerebell ...... l-Lindau disease: case report.
@nl
type
label
Pazopanib therapy for cerebell ...... l-Lindau disease: case report.
@en
Pazopanib therapy for cerebell ...... l-Lindau disease: case report.
@nl
prefLabel
Pazopanib therapy for cerebell ...... l-Lindau disease: case report.
@en
Pazopanib therapy for cerebell ...... l-Lindau disease: case report.
@nl
P2860
P1433
P1476
Pazopanib therapy for cerebell ...... el-Lindau disease: case report
@en
P2093
Eric Jonasch
Ian E McCutcheon
P2860
P2888
P304
P356
10.1007/S11523-012-0214-0
P50
P577
2012-02-29T00:00:00Z